The Current Ratio as of December 2025 (TTM) for SinoMab BioScience Limited (3681.HK) is 0.87

According to SinoMab BioScience Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.87. This represents a change of -25.55% compared to the average of 1.16 of the last 4 quarters.

SinoMab BioScience Limited (3681.HK) Historical Current Ratio (quarterly & annually)

How has 3681.HK Current Ratio performed in the past?

The mean historical Current Ratio of SinoMab BioScience Limited over the last ten years is 5.08. The current 0.87 Current Ratio has changed 1.60% with respect to the historical average. Over the past ten years (40 quarters), 3681.HK's Current Ratio was at its highest in in the June 2020 quarter at 27.48. The Current Ratio was at its lowest in in the January 2017 quarter at 0.

SinoMab BioScience Limited (3681.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of SinoMab BioScience Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SinoMab BioScience Limited (3681.HK) Average Current Ratio

How has 3681.HK Current Ratio performed in the past?

The current Current Ratio of SinoMab BioScience Limited (3681.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

SinoMab BioScience Limited (3681.HK) Current Ratio vs. Peers

How is 3681.HK’s Current Ratio compared to its peers?

SinoMab BioScience Limited’s Current Ratio is less than HighTide Therapeutics Inc (3.44), less than Mabpharm Limited (1.07), less than Shanghai Bio-heart Biological Technology Co., Ltd. (12.65), less than Cutia Therapeutics (3.16), greater than Immunotech Biopharm Ltd (0.08), less than Zhaoke Ophthalmology Limited (4.40), less than 3D Medicines Inc. (1.59), less than JW (Cayman) Therapeutics Co. Ltd (1.59), less than Frontage Holdings Corporation (1.24), less than C-MER Medical Holdings Limited (1.51),

Build a custom stock screener for SinoMab BioScience Limited (3681.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SinoMab BioScience Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SinoMab BioScience Limited (3681.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SinoMab BioScience Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.